Invention Grant
- Patent Title: Tricyclic compounds as anticancer agents
-
Application No.: US15150492Application Date: 2016-05-10
-
Publication No.: US09725449B2Publication Date: 2017-08-08
- Inventor: Derek J. Norris , Wayne Vaccaro , Mikkel V. DeBenedetto , Andrew P. Degnan , George V. Delucca , Jeffrey A. Deskus , Wen-Ching Han , Godwin Kwame Kumi , William D. Schmitz , John E. Starrett, Jr. , Matthew D. Hill , Hong Huang
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- Main IPC: C07D471/14
- IPC: C07D471/14 ; A61K31/4375 ; A61K31/439 ; A61K31/444 ; A61K31/4545 ; A61K31/496 ; A61K31/519 ; A61K31/5377 ; A61K31/541 ; A61K31/554 ; A61K31/675 ; A61K31/683 ; C07D519/00 ; C07F9/6561
Abstract:
The present invention is directed to tricyclic compounds of the formula wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Public/Granted literature
- US20160333013A1 TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS Public/Granted day:2016-11-17
Information query
